ArticleRevista peruana de medicina experimental y salud publica2025
Epidemiology and treatment in patients with HIV in a secondary-level hospital in Mexico.
Article in Revista peruana de medicina experimental y salud publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To describe the sociodemographic, clinical, and therapeutic characteristics of patients with Human Immunodeficiency Virus (HIV) at a second-level hospital in Mexico, a descriptive study was conducted based on the review and analysis of 871 clinical records from 2017 to 2023. The results show a predominance of the male sex (91.5%) with ages between 30 and 39 years (45.5%), and a homosexual sexual orientation (68.0%). About 25.4% had an initial CD4 count of <200 cells, 99% received antiretroviral therapy (ART), and subsequently 54.5% had a CD4 count of >500 cells, 88.1% presented with an undetectable viral load, and 1.6% experienced treatment failure. In conclusion, the young, single, homosexual male population is vulnerable to HIV infection. These findings highlight the need to strengthen prevention programs, timely diagnosis, and early treatment, to improve clinical outcomes and reduce HIV transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.